Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004354 · ClinicalTrials.gov registry record
Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00004354: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00004354 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004354 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in various hypertensive populations and screen at risk members of GRA pedigrees. II. Investigate other factors regulating blood pressure in GRA (environmental, genetically determined factors). III. Investigate renal and hormonal mechanisms regulating potassium homeostasis in GRA. IV. Describe clinical phenotype of GRA patients. V. Prospectively screen GRA-affected patients with MRI angiography for intracranial aneurysm.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-06 |
What the finished NCT00004354 record still lists
NCT00004354 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00004354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004354 about?
NCT00004354 is a clinical study titled "Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism". OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in various hypertensive populations and screen at risk members of GRA pedigrees. II. Investigate other factors regulating blood pressure in GRA (environmental, genetically determined factors). III. Investigate...
What is the current status of trial NCT00004354?
This trial is currently completed. The study started on 1999-06.
Who is sponsoring clinical trial NCT00004354?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia